It has been reported that the proportion of MMR defects is higher in tumors of larger volume in patients with endometrial cancer (27, 28), a finding that is consistent with the increased MTV we observed in patients with Lynch syndrome. The gene discussed is MRC1; the disease is endometrial cancer.